Search

25 results for “World Health Organization (WHO)”

• Open Access

  A closer look at the World Health Organization’s prescribing indicators Richard Ofori‑Asenso

  Research Unit, Health Policy Consult, Weija Weija, Accra Accra, Ghana Ghana

  Vol. 7 · Issue 1 · pp. 51–54

  https://doi.org/10.4103/0976-500X.179352
  Full text ↗PDF

• CorrespondenceOpen Access

  World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies

  B. Gitanjali

  Vol. 2 · Issue 4 · pp. 308–309

  https://doi.org/10.4103/0976-500X.85943
  Full text ↗PDF

• WebwiseOpen Access

  Essential medicines and health products information portal

  P. Ravi Shankar

  Vol. 5 · Issue 1 · pp. 74–5

  https://doi.org/10.4103/0976-500X.124434
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• Review ArticleOpen Access

  Cephalosporins Use in Pediatric Healthcare: A Comprehensive Review and Policy Considerations in Kingdom of Saudi Arabia

  Mohammed K. Alshammari, Hind M. Al Osaimi, Norah F. Alshehri, Raneem F. Masoud, Alaa O. Abdulaal, Bashair Z. Al Qaidi

  Vol. 16 · Issue 2 · pp. 129–142

  https://doi.org/10.1177/0976500X241303306
  Full text ↗PDF

• Research LetterOpen Access

  Cross sectional surveillance of drug dispensing efficacy, availability and quality of labelling by patient care indicators in health care facilities

  Lukshmy M. Hettihewa, Kalana Jayarathna, Sewwandi Subasinghe

  Vol. 4 · Issue 2 · pp. 142–143

  https://doi.org/10.4103/0976-500X.110898
  Full text ↗PDF

• EditorialOpen Access

  The national essential medicines list of India: Time to revise and purge the mistakes

  Gitanjali B

  Vol. 1 · Issue 2 · pp. 73–74

  https://doi.org/10.4103/0976-500X.72346
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF

• Review ArticleOpen Access

  Riociguat: Something new in pulmonary hypertension therapeutics?

  Elangovan Shanmugam, Amrita Jena, Melvin George

  Vol. 6 · Issue 1 · pp. 3–6

  https://doi.org/10.4103/0976-500X.149132
  Full text ↗PDF

• Research LettersOpen Access

  Antidiabetic activity of stem bark of Bauhinia variegata in alloxan-induced hyperglycemic rats

  Parveen Kumar, Shailesh Baraiya, S. N. Gaidhani, M. D. Gupta, Manish M. Wanjari

  Vol. 3 · Issue 1 · pp. 64–65

  https://doi.org/10.4103/0976-500X.92522
  Full text ↗PDF

• CorrespondenceOpen Access

  Are we moving towards a new definition of essential medicines?

  Marcus M. Reidenberg

  Vol. 6 · Issue 4 · pp. 233–233

  https://doi.org/10.4103/0976-500X.171874
  Full text ↗PDF

• Research ArticleOpen Access

  Non-invasive Anemia Detection and Prediagnosis

  Santosh Aiwale, Mahesh T. Kolte, Varsha Harpale, Varsha Bendre, Deepti Khurge, Sheetal Bhandari, Suvarna Kadam, Altaf O. Mulani

  Vol. 15 · Issue 4 · pp. 408–416

  https://doi.org/10.1177/0976500X241276307
  Full text ↗PDF

• Research ArticleOpen Access

  Critical Evaluation of Drug Promotional Literature Using WHO Ethical Criteria and Perception of Clinicians at a Tertiary Care Hospital

  Amanjot Kaur, Shweta Singla, Mandeep Kaur, Jasninder Singh

  Vol. 14 · Issue 1 · pp. 41–46

  https://doi.org/10.1177/0976500X231164812
  Full text ↗PDF

• Research LetterOpen Access

  Availability of the Essential Medicines is Community Pharmacies: A Cross-Sectional Study

  Pallavi Jha, Sneha Ambwani, Surjit Singh, Pankaj Bhardwaj, Shobhan Babu Varthya, Jaykaran Charan

  Vol. 13 · Issue 1 · pp. 92–94

  https://doi.org/10.1177/0976500X221080370
  Full text ↗PDF

• Research LetterOpen Access

  Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools

  Niti Mittal, Mahesh C. Gupta

  Vol. 6 · Issue 2 · pp. 91–93

  https://doi.org/10.4103/0976-500X.155486
  Full text ↗PDF

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• Case ReportOpen Access

  Skin rash during treatment with generic itraconazole

  Antonio De Vuono, Caterina Palleria, Francesca Scicchitano, Aida Squillace, Giovambattista De Sarro, Luca Gallelli

  Vol. 5 · Issue 2 · pp. 158–160

  https://doi.org/10.4103/0976-500X.130086
  Full text ↗PDF

• Case ReportOpen Access

  Oyster shell calcium induced parotid swelling

  Muthiah Palaniappan, Sandhiya Selvarajan, Sureshkumar Srinivasamurthy, Adithan Chandrasekaran

  Vol. 5 · Issue 4 · pp. 256–257

  https://doi.org/10.4103/0976-500X.142446
  Full text ↗PDF

• Research LetterOpen Access

  Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital

  Raghava Sharma, Adithi Kellarai

  Vol. 5 · Issue 4 · pp. 248–250

  https://doi.org/10.4103/0976-500X.142436
  Full text ↗PDF

• Research PaperOpen Access

  Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India

  Binit N. Jhaveri, Tejas K. Patel, Manish J. Barvaliya, C. B. Tripathi

  Vol. 5 · Issue 1 · pp. 15–16

  https://doi.org/10.4103/0976-500X.124411
  Full text ↗PDF